The First Hospital of Jilin University
π¨π³China
- Country
- π¨π³China
- Ownership
- -
- Established
- 1920-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.bethune-jilin.cn
Effects of Different Genetic Mutations on Prognosis in sMPLC Adenocarcinoma Patients
- Conditions
- Interventions
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2021-10-14
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 20
- Registration Number
- NCT03764371
- Locations
- π¨π³
The first hospital of Jilin University, Changchun, Jilin, China
Apatinib Combined With Chemotherapy for NSCLC Patients Without T790M Mutation
- First Posted Date
- 2018-11-29
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 30
- Registration Number
- NCT03758677
- Locations
- π¨π³
The First Hospital of Jilin University, Changchun, Jilin, China
Study on the Mechanism of Neurodevelopment Dysplasia of Fetal Brain Caused by ASNS Gene Mutation
- First Posted Date
- 2018-07-16
- Last Posted Date
- 2018-07-16
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 10
- Registration Number
- NCT03587155
- Locations
- π¨π³
Bo Chen, Chang Chun, Jilin, China
The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-06-06
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 228
- Registration Number
- NCT03546530
A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer
- First Posted Date
- 2018-06-06
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 31
- Registration Number
- NCT03547804
- Locations
- π¨π³
The First Hospital Of Jilin University, Changchun, Jilin, China
The Curative Effect of Entecavir Combined Resveratrol on HBV patients-a Multi-center, Random, Open Clinical Trial
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-04-26
- Last Posted Date
- 2018-04-26
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 312
- Registration Number
- NCT03509688
Concurrent Intrathecal-pemetrexed and Involved-field Radiotherapy for Leptomeningeal Metastasis From Solid Tumors
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2018-04-25
- Last Posted Date
- 2019-12-26
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 34
- Registration Number
- NCT03507244
- Locations
- π¨π³
The First Hospital of Jilin University, Changchun, Jilin, China
Factors Contribute to Very Late Stent Thrombosis After New Generation DES Implantation in China
Completed
- Conditions
- First Posted Date
- 2018-04-09
- Last Posted Date
- 2019-09-20
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 8476
- Registration Number
- NCT03491891
- Locations
- π¨π³
Jilin University 1st Hospital, Changchun, Jilin, China
The Relationship Between Right-to-left Shunt and Brain White Matter Lesions in Patients With Migraine
- First Posted Date
- 2018-02-01
- Last Posted Date
- 2020-07-23
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 1500
- Registration Number
- NCT03418766
- Locations
- π¨π³
First hospital of Jilin Uni, Changchun, Jilin, China
Influence of Bilateral Arm Ischemic Postconditioning on Clinical Prognosis and Outcome in Acute Ischemic Stroke Patients
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2017-11-07
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 100
- Registration Number
- NCT03335111
- Locations
- π¨π³
First hospital of Jilin University, Changchun, Jilin, China
Β© Copyright 2024. All Rights Reserved by MedPath